255 related articles for article (PubMed ID: 33845354)
1. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
[TBL] [Abstract][Full Text] [Related]
2. Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis.
Azevedo H; Pessoa GC; de Luna Vitorino FN; Nsengimana J; Newton-Bishop J; Reis EM; da Cunha JPC; Jasiulionis MG
Clin Epigenetics; 2020 Aug; 12(1):127. PubMed ID: 32831131
[TBL] [Abstract][Full Text] [Related]
3. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.
de Souza CF; Xander P; Monteiro AC; Silva AG; da Silva DC; Mai S; Bernardo V; Lopes JD; Jasiulionis MG
PLoS One; 2012; 7(9):e44800. PubMed ID: 22984562
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival.
Rius FE; Papaiz DD; Azevedo HFZ; Ayub ALP; Pessoa DO; Oliveira TF; Loureiro APM; Andrade F; Fujita A; Reis EM; Mason CE; Jasiulionis MG
Clin Epigenetics; 2022 May; 14(1):68. PubMed ID: 35606887
[TBL] [Abstract][Full Text] [Related]
5. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
[TBL] [Abstract][Full Text] [Related]
6. Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma.
Siena ÁDD; Plaça JR; Araújo LF; de Barros II; Peronni K; Molfetta G; de Biagi CAO; Espreafico EM; Sousa JF; Silva WA
Sci Rep; 2019 Aug; 9(1):11350. PubMed ID: 31383874
[TBL] [Abstract][Full Text] [Related]
7. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells.
Vlčková K; Vachtenheim J; Réda J; Horák P; Ondrušová L
J Cell Mol Med; 2018 Apr; 22(4):2240-2251. PubMed ID: 29369499
[TBL] [Abstract][Full Text] [Related]
8. Melanoma Progression Inhibits Pluripotency and Differentiation of Melanoma-Derived iPSCs Produces Cells with Neural-like Mixed Dysplastic Phenotype.
Castro-Pérez E; Rodríguez CI; Mikheil D; Siddique S; McCarthy A; Newton MA; Setaluri V
Stem Cell Reports; 2019 Jul; 13(1):177-192. PubMed ID: 31231022
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression.
Ryu B; Kim DS; Deluca AM; Alani RM
PLoS One; 2007 Jul; 2(7):e594. PubMed ID: 17611626
[TBL] [Abstract][Full Text] [Related]
10. Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
Wang S; Fan W; Wan B; Tu M; Jin F; Liu F; Xu H; Han P
PLoS One; 2017; 12(2):e0172498. PubMed ID: 28225791
[TBL] [Abstract][Full Text] [Related]
11. Cooperative behaviour and phenotype plasticity evolve during melanoma progression.
Rowling EJ; Miskolczi Z; Nagaraju R; Wilcock DJ; Wang P; Telfer B; Li Y; Lasheras-Otero I; Redondo-Muñoz M; Sharrocks AD; Arozarena I; Wellbrock C
Pigment Cell Melanoma Res; 2020 Sep; 33(5):695-708. PubMed ID: 32145051
[TBL] [Abstract][Full Text] [Related]
12. Genes regulated by DNA methylation are involved in distinct phenotypes during melanoma progression and are prognostic factors for patients.
Papaiz DD; Rius FE; Ayub ALP; Origassa CS; Gujar H; Pessoa DO; Reis EM; Nsengimana J; Newton-Bishop J; Mason CE; Weisenberger DJ; Liang G; Jasiulionis MG
Mol Oncol; 2022 May; 16(9):1913-1930. PubMed ID: 35075772
[TBL] [Abstract][Full Text] [Related]
13. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
[TBL] [Abstract][Full Text] [Related]
14. Loss of prdm1a accelerates melanoma onset and progression.
Iwanaga R; Truong BT; Hsu JY; Lambert KA; Vyas R; Orlicky D; Shellman YG; Tan AC; Ceol C; Artinger KB
Mol Carcinog; 2020 Sep; 59(9):1052-1063. PubMed ID: 32562448
[TBL] [Abstract][Full Text] [Related]
15. Systems analysis identifies miR-29b regulation of invasiveness in melanoma.
Andrews MC; Cursons J; Hurley DG; Anaka M; Cebon JS; Behren A; Crampin EJ
Mol Cancer; 2016 Nov; 15(1):72. PubMed ID: 27852308
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic reprogramming as a key contributor to melanocyte malignant transformation.
Molognoni F; Cruz AT; Meliso FM; Morais AS; Souza CF; Xander P; Bischof JM; Costa FF; Soares MB; Liang G; Jones PA; Jasiulionis MG
Epigenetics; 2011 Apr; 6(4):450-64. PubMed ID: 21343701
[TBL] [Abstract][Full Text] [Related]
17. Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures.
Fontana F; Sommariva M; Anselmi M; Bianchi F; Limonta P; Gagliano N
Cells; 2024 Jan; 13(2):. PubMed ID: 38247872
[TBL] [Abstract][Full Text] [Related]
18. The CASC15 Long Intergenic Noncoding RNA Locus Is Involved in Melanoma Progression and Phenotype Switching.
Lessard L; Liu M; Marzese DM; Wang H; Chong K; Kawas N; Donovan NC; Kiyohara E; Hsu S; Nelson N; Izraely S; Sagi-Assif O; Witz IP; Ma XJ; Luo Y; Hoon DSB
J Invest Dermatol; 2015 Oct; 135(10):2464-2474. PubMed ID: 26016895
[TBL] [Abstract][Full Text] [Related]
19. Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes.
Chiu KP; Ariyaratne P; Xu H; Tan A; Ng P; Liu ET; Ruan Y; Wei CL; Sung WK
BMC Cancer; 2007 Jun; 7():109. PubMed ID: 17594473
[TBL] [Abstract][Full Text] [Related]
20. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
